Searching across hundreds of databases
Hypertrophic cardiomyopathy (HCM) is a common cardiovascular disease. However, effective methods of its therapy have not been developed so far. To date patient-specific induced pluripotent stem cell-derived cardiomyocytes are supposed to be a useful tool for studying HCM molecular mechanisms and to help find new approaches to HCM therapy. Using non-integrating episomal vectors, we generated an iPSC line from peripheral blood mononuclear cells of an HCM patient carrying a heterozygous p.N515del mutation in MYBPC3. The iPSC line expressed pluripotency markers, gave rise to derivatives of three germ layers during spontaneous differentiation, had normal karyotype, and retained the patient-specific mutation.
Pubmed ID: 33892289 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG1
View all literature mentionsThis polyclonal secondary targets IgG2a
View all literature mentionsThis polyclonal secondary targets IgG3
View all literature mentionsThis polyclonal secondary targets IgM (Heavy chain)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis monoclonal targets HNF-3beta (H-4)
View all literature mentionsThis monoclonal targets Cytokeratin 18
View all literature mentionsThis polyclonal targets Collagen I
View all literature mentionsThis monoclonal targets Smooth Muscle Actin
View all literature mentionsThis unknown targets Neurofilament 200
View all literature mentionsThis monoclonal targets Neuronal Class III beta-Tubulin (TUJ1) Purified
View all literature mentionsThis monoclonal targets SSEA4 antibody [MC813] - Embryonic Stem Cell Marker
View all literature mentionsThis monoclonal targets Human TRA-1-60 (R)
View all literature mentionsThis polyclonal targets Human Nanog peptide
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
